←Back to Expert Scholars
Translational Medicine / 转化医学NTRK and Rare Gene Fusions
Anna Farago
MD, PhD
🏢Massachusetts General Hospital🌐USA
Associate Professor of Medicine
45
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Anna Farago specializes in rare molecular subtypes of lung cancer including NTRK and RET fusion-positive tumors. Her clinical research has contributed to understanding response patterns and resistance to TRK inhibitors. She has been a key investigator in multi-histology basket trials for NTRK-targeted therapy.
Share:
🧪Research Fields 研究领域
NTRK fusions
RET fusions
Small cell lung cancer
Molecular therapeutics
Rare driver mutations
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Anna Farago 的研究动态
Follow Anna Farago's research updates
留下邮箱，当我们发布与 Anna Farago（Massachusetts General Hospital）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment